Cardiovascular therapeutics that mimic the biological actions of pyridoxine and pyridoxal Feb. 20, 2002
Potential antianginal efficacy of the selective, orally active Na+/H+ exchange inhibitor SMP-300 Feb. 19, 2002
F-12511 reduces hypercholesterolemia and progression of atherosclerotic lesions in rabbit model Feb. 18, 2002
Boehringer Ingelheim signs on major Japanese pharmaceutical firm to copromote telmisartan Feb. 14, 2002